Le Lézard
Classified in: Covid-19 virus
Subject: FOOD/COOKING

Restaurants Canada is urging Parliament to expand federal support programs


TORONTO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Now that Parliament has returned, Restaurants Canada is eager to get back to work with elected officials to ensure that hard-hit foodservice businesses will have enough federal support to get through the winter.

"Restaurants are key to reviving main streets across Canada and feeding our country's economic recovery, but first they need to survive," said Restaurants Canada President and CEO Todd Barclay. "Federal support programs are currently too restrictive and will leave far too many hardworking restaurant operators out in the cold as they continue to cope with the ongoing pandemic. While our government has been on a break, the 90,000+ small and medium-sized businesses that make up our critically important foodservice sector have been fighting to keep their doors open. They deserve federal support programs that will help them continue contributing to the social and economic fabric of their communities."

Survey results reveal gap between available support and level of need

According to the latest survey data from Restaurants Canada:

Without better access to financial support, most foodservice businesses will struggle to keep paying their staff, and many will have to consider closing down for good under the weight of crushing debt.

Recommendations from Restaurants Canada

Restaurants Canada is calling for the following changes to federal support programs to help foodservice businesses continue contributing to jobs, economic growth and vibrant neighbourhoods across the country:

For more information on what Canada's restaurants need to stay in the picture as they continue to navigate the ongoing pandemic, visit: SupportRestaurants.ca

About Restaurants Canada

Restaurants Canada is a national, not-for-profit association advancing the potential of Canada's diverse and dynamic foodservice industry through member programs, research, advocacy, resources and events. Before the start of the COVID-19 pandemic, Canada's foodservice sector was a $95 billion industry, directly employing 1.2 million people, providing Canada's number one source of first jobs and serving 22 million customers across the country every day. The industry has since lost hundreds of thousands of jobs and billions in sales due to the impacts of COVID-19.

For media inquiries please contact Elizabeth Glassen of BlueSky Communications at:

BlueSky Communications
Elizabeth Glassen, Account Manager
Telephone: +1 (647) 309-0141
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/38df280e-6bb4-4d7c-af9f-49ecc81b4a86



These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: